{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:10:15Z","timestamp":1767773415413,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jdmv.2020.01.153","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T08:29:10Z","timestamp":1580977750000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ischemic stroke and non-valvular atrial fibrillation: When to introduce anticoagulant therapy?"],"prefix":"10.1016","volume":"45","author":[{"given":"V.","family":"Boursier-Bossy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Emmerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2020.01.153_bib0275","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1160\/TH16-03-0217","article-title":"Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation","volume":"116","author":"Paciaroni","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0280","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","article-title":"INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study","volume":"388","author":"O\u2019Donnell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0285","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/hs1001.097093","article-title":"Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischaemic stroke and atrial fibrillation in the International Stroke Trial","volume":"32","author":"Saxena","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0290","first-page":"2719","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"European Society of Cardiology","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0295","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0300","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/STROKEAHA.116.015770","article-title":"Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study","volume":"48","author":"Paciaroni","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0305","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clineuro.2018.08.026","article-title":"Prediction of hemorrhagic transformation in patients with mild atrial fibrillation-associated stroke treated with early anticoagulation: post hoc analysis of the Triple AXEL Trial","volume":"174","author":"Lee","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0310","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000229781","article-title":"Frequency and Determinants for Hemorrhagic Transformation of Cerebral Infarction","volume":"33","author":"Terruso","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0315","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000331702","article-title":"Predictors and Early Outcome of Hemorrhagic Transformation after Acute Ischemic Stroke","volume":"32","author":"Kablau","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0320","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome. Results of a Prospective Multicenter Study","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0325","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00415-014-7297-8","article-title":"Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis","volume":"261","author":"Tan","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0330","doi-asserted-by":"crossref","first-page":"e010133","DOI":"10.1161\/JAHA.118.010133","article-title":"Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes","volume":"7","author":"Paciaroni","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0335","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/STROKEAHA.107.492330","article-title":"Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial","volume":"39","author":"Yong","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0340","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/STROKEAHA.110.595561","article-title":"The Significance of Blood Pressure Variability for the Development of Hemorrhagic Transformation in Acute Ischemic Stroke","volume":"41","author":"Youngchai","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0345","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.25434","article-title":"Blood Pressure Variability and Hemorrhagic Transformation in Patients with Successful Recanalization after Endovascular Recanalization Therapy: A Retrospective Observational Study","volume":"85","author":"Tae Jung","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0350","first-page":"637","article-title":"Histopathologic Analysis of Foci of Signal Loss on Gradient-Echo T2*-Weighted MR Images in Patients With Spontaneous Intracerebral Hemorrhage: Evidence of Microangiopathy-Related Microbleeds","volume":"20","author":"Fazekas","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0355","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","article-title":"International META-MICROBLEEDS Initiative. Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","article-title":"Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study","volume":"17","author":"Wilson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0365","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.56.4.537","article-title":"Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston Criteria","volume":"56","author":"Knudsen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.22112","article-title":"Cerebral Amyloid Angiopathy Pathology and Cognitive Domains in Older Persons","volume":"69","author":"Arvanitakis","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0375","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2017.07.724","article-title":"Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation","volume":"70","author":"De Simone","year":"2017","journal-title":"Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0380","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0385","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(08)60168-3","article-title":"Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial","volume":"371","author":"Amadeus Investigators","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.jdmv.2020.01.153_bib0390","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0395","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0400","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0405","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0410","doi-asserted-by":"crossref","first-page":"e601S","DOI":"10.1378\/chest.11-2302","article-title":"Antithrombotic and Thrombolytic Therapy for Ischemic Stroke. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Lansberg","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0415","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0420","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(13)70079-6","article-title":"Targeted use of heparin, heparinoids, or low-molecular weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials","volume":"12","author":"Whiteley","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0425","first-page":"CD000024","article-title":"Anticoagulants for acute ischaemic stroke","author":"Sandercock","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0430","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0435","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ene.12577","article-title":"Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA","volume":"22","author":"Abdul-Rahim","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","article-title":"Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation","volume":"18","author":"Seiffge","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0445","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","article-title":"Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events","volume":"87","author":"Seiffge","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0450","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study","volume":"6","author":"Paciaroni","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0455","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1253\/circj.CJ-16-0923","article-title":"Timing of treatment initiation with oral anticoagulants for acute ischemic stroke in patients with nonvalvular atrial fibrillation","volume":"81","author":"Deguchi","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0460","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.031","article-title":"Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke","volume":"25","author":"Macha","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0465","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/STROKEAHA.116.013491","article-title":"Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic transformation: a prospective magnetic resonance imaging study","volume":"47","author":"Gioia","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0470","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1747493016632239","article-title":"Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study","volume":"11","author":"Arihiro","year":"2016","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0475","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study","volume":"90","author":"Wilson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0480","first-page":"1206","article-title":"Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial. JAMA Neurol","volume":"74","author":"Hong","year":"2017"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0485","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s13063-017-2313-9","article-title":"Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial (NCT02961348)","volume":"18","author":"Asberg","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0490","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0495","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2396987317699144","article-title":"Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13-15 November 2016","volume":"2","author":"Ahmed","year":"2017","journal-title":"Eur Stroke J"},{"year":"2014","series-title":"Pr\u00e9vention vasculaire apr\u00e8s un infarctus c\u00e9r\u00e9bral ou un accident isch\u00e9mique transitoire. Recommandation de bonne pratique","key":"10.1016\/j.jdmv.2020.01.153_bib0500"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0505","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/STROKEAHA.118.021514","article-title":"Continuation or Discontinuation of Anticoagulation in the Early Phase After Acute Ischemic Stroke","volume":"49","author":"Groot","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0510","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0515","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0520","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0525","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0530","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in non valvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdmv.2020.01.153_bib0535","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.25489","article-title":"CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation","volume":"85","author":"Seiffge","year":"2019","journal-title":"Ann Neurol"},{"year":"2013","series-title":"Fibrillation auriculaire non valvulaire. Quelle place pour les anticoagulants oraux ? Bon usage du m\u00e9dicament","key":"10.1016\/j.jdmv.2020.01.153_bib0540"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254245132030153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254245132030153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:04:58Z","timestamp":1762869898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S254245132030153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S254245132030153X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2020.01.153","relation":{},"ISSN":["2542-4513"],"issn-type":[{"type":"print","value":"2542-4513"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic stroke and non-valvular atrial fibrillation: When to introduce anticoagulant therapy?","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2020.01.153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}